Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Seattle WA, Olympia WA, Vancouver WA, Portland OR,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Seattle WA, Portland OR, Reno NV, Walnut Creek CA,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Get alerts for new trials in your area by subscribing now
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Seattle WA, Edmonton, Palo Alto CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Seattle WA, Vancouver, Edmonton, San Francisco CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase 3, Recruiting
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for
Acute Hepatic Porphyria
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 12+
Code: NCT04883905
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Seattle WA, Abbotsford British Columbia, Burnaby,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Seattle WA, Surrey, Springfield OR, Idaho Falls ID,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
for
Lupus Erythematosus, Systemic
Location: Seattle WA, San Francisco CA, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06897930
Phase 1, Phase 2, Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Seattle WA, Kirkland WA, Tacoma WA, Sacramento CA,
Sponsor: Biomed Industries, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04452565
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
for
Influenza, Human+COVID-19
Location: Seattle WA, Fair Oaks CA, San Diego CA, Austin TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65 - 70+
Code: NCT07464314
Phase 1, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Seattle WA, Olympia WA, San Francisco CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
for
HIV Infections
Location: Seattle WA, Bakersfield CA, West Hollywood CA,
Sponsor: ViiV Healthcare
Sex: All
Age: 18+
Code: NCT07202546
Phase 2, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).